Skip to content

The effect of salt-reduction smartphone app based on cognitive behavioral intervention in patients with chronic kidney disease and hypertension: a prospective randomized controlled trial

The effect of salt-reduction smartphone app based on cognitive behavioral intervention in patients with chronic kidney disease and hypertension: a prospective randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200060627
Enrollment
Unknown
Registered
2022-06-06
Start date
2022-05-31
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease

Interventions

A:Smartphone APP group

Sponsors

Xinqiao Hospital, Army Medical University (Third Military Medical University)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) 18-65 years old; (2) CKD4-5 or CKD1-3 with hypertension; (3) 24-hour urinary sodium excretion > 130mmol/d; (4) Self-care (Bathel score > 60); (5) Normal intelligence (MMSE score >=24) (6) Proficient in the use of mobile apps; (7) Signed informed consent.

Exclusion criteria

Exclusion criteria: (1) Rapid and persistent decline in eGFR (AKI); (2) Kidney transplantation within 1 year; (3) cardiovascular events occurred within 6 months; (4) Systolic blood pressure >160 mmHg or diastolic blood pressure >100 MMHG; (5) Have participated in similar studies before; (6) Other medical conditions may interfere with the completion of the study.

Design outcomes

Primary

MeasureTime frame
Sodium urine 24 hours;Blood pressure (systolic/diastolic);Incidence of renal end-point events: including ESKD and renal replacement therapy (hemodialysis, peritoneal dialysis, and kidney transplantation);Rate of renal function progression: the slope of change in glomerular filtration rate (eGFR) before and after intervention;;

Secondary

MeasureTime frame
30 days unplanned readmission;60 days unplanned readmission;30 days of unplanned all-cause death;60 days of unplanned all-cause death;Cardiovascular and cerebrovascular events (including myocardial infarction, coronary heart disease, angina pectoris, arrhythmia, heart failure, cardiac arrest, death from cerebrovascular events, etc.);Urine protein quantification: random urine protein/creatinine ratio / 24-hour urine protein quantification;

Countries

China

Contacts

Public ContactShi Yu

Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing

Shiyu618@tmmu.edu.cn+86 18580642512

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026